Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
Favrot
M
M
Bone Marrow Transplant Unit, Centre Léon Bérard, Lyon, France.
Philip
I
I
Combaret
V
V
Pavone
E
E
Bouffet
E
E
Biron
P
P
Philip
T
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D003165:Complement System Proteins / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D005069:Evaluation Studies as Topic; D006801:Humans; D014411:Neoplastic Stem Cells / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology / Q000473:pathology / Q000601:surgery*; D014182:Transplantation, Autologous; D014407:Tumor Cells, Cultured / Q000276:immunology; D014410:Tumor Stem Cell Assay
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D003165:Complement System Proteins